MCU knockdown attenuates cisplatin-induced damage of auditory cells: potential involvement of PI3K/AKT/mTOR signaling and autophagy-related processes.

Introduction: The mitochondrial calcium uniporter (MCU) mediates mitochondrial Ca Methods: MCU protein abundance and localization were assessed by Western blotting and immunofluorescence. MCU expression was genetically reduced by lentiviral knockdown, and Ru360 was used as a pharmacological intervention. Apoptosis-related proteins and transcriptomic changes were evaluated. An acute cisplatin-induced ototoxicity model was established in C57BL/6 mice and assessed using auditory brainstem response (ABR) measurements and outer hair cell counts. Results: Cisplatin increased MCU expression and reduced SERCA2 expression; the cisplatin-induced increase in MCU was partially reversed by BAPTA-AM and the endoplasmic reticulum stress inhibitor 4-PBA. MCU knockdown did not affect basal cell viability but attenuated cisplatin-induced reductions in viability, TUNEL positivity, and cleaved caspase-3. It was also associated with increased SERCA2 and decreased IP3R, GRP75, and VDAC1 expression. RNA sequencing identified differentially expressed genes enriched in autophagy-related processes and mTOR signaling. MCU knockdown was associated with increased PI3K/AKT/mTOR signaling and changes in Beclin1, LC3B-II, and p62. Ru360 cotreatment partially reproduced the protective phenotype Discussion: These findings support an association between MCU-related signaling, PI3K/AKT/mTOR pathway activation, altered autophagy-related markers, and reduced cisplatin-induced cochlear injury.